August 2018 FDA Recall Drug by Akorn, Inc.
D-1183-2018 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Akorn, Inc. on August 24, 2018 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1183-2018

Reason for Recall
Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.
Initiated
08-24-2018
Reported
09-12-2018
Quantity
23,788 100-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA
Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated, Maroerre, GA 30062. Mfg By: Swiss Caps AG, Kirchberg, Switzerland. NDC: 61748-025-01

Batch or Lot Expiration Information

Lot# Lots: 1165280100, 1165280101, EXP 3/2019